Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma
University of Washington
University of Washington
Fox Chase Cancer Center
National Cancer Institute (NCI)
Roswell Park Cancer Institute